SCHEMBL16769985

SCHEMBL16769985

Clc1ncnc2c1ccn2C1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP4K2A P48426 1/20 0.42
PRMT5 O14744 2/20 0.41
WDR77 Q9BQA1 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.38
HCK P08631 3/20 0.37
SRC P12931 3/20 0.37
LCK P06239 1/20 0.37
TEK Q02763 1/20 0.37
SLC22A12 Q96S37 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
HRH3 Q9Y5N1 2/20 0.36
RET P07949 3/20 0.36
MEN1 O00255 1/20 0.36
HCAR1 Q9BXC0 1/20 0.35
KDR P35968 3/20 0.35
PIK3CD O00329 2/20 0.35
ABL1 P00519 2/20 0.35
EGFR P00533 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16967987 0.89 PIP4K2A (0.49) PIP4K2APRMT5WDR77SRCSLC22A12
SCHEMBL24753099 0.86 PIP4K2A (0.44) PIP4K2APRMT5WDR77HCKSRC
SCHEMBL1939828 0.86 PIP4K2A (0.44) PIP4K2APRMT5WDR77HCKSRC
SCHEMBL12984832 0.85 PRMT5 (0.42) PIP4K2APRMT5WDR77SLC22A12
SCHEMBL17877686 0.85 PIP4K2A (0.44) PIP4K2APRMT5WDR77SRCLCK
SCHEMBL12649114 0.82 PIP4K2A (0.42) PIP4K2APRMT5WDR77SLC22A12HRH3
SCHEMBL1442965 0.82 PIP4K2A (0.45) PIP4K2APRMT5WDR77SRCLCK
SCHEMBL1442966 0.82 PIP4K2A (0.45) PIP4K2APRMT5WDR77SRCLCK
SCHEMBL12596590 0.82 PIP4K2A (0.42) PIP4K2APRMT5WDR77HCKSRC
SCHEMBL15636715 0.82 PIP4K2A (0.45) PIP4K2APRMT5WDR77SRCLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158697-A1 Protein Kinase Inhibitors PHARMASCIENCE INC. (CA) 2017-06-08 US disclosed
US-20170158697-A1 Protein Kinase Inhibitors PHARMASCIENCE INC. (CA) 2017-06-08 US disclosed
WO-2015077866-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE INC. (CA) 2015-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158697-A1 Protein Kinase Inhibitors TEC, LCK, SRC PIP4K2A 335/4885PRMT5 792/4885WDR77 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.